- YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells
Zhi Liu et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef - Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy
Sugata Barui et al, 2020, Pharmaceutics CrossRef - PNA-ATP aptamer-capped doxorubicin-loaded silica nanoparticles for targeted cancer therapy
Youkabed Kazemi et al, 2022, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef - A systematic review of emerging technologies to enhance the treatment of ovarian cancer
Samaneh Sepahi et al, 2023, Pharmaceutical Development and Technology CrossRef - The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine
Cailin O’Connell et al, 2022, International Journal of Molecular Sciences CrossRef - Co-Delivery System of Curcumin and Colchicine Using Functionalized Mesoporous Silica Nanoparticles Promotes Anticancer and Apoptosis Effects
Khaled AbouAitah et al, 2022, Pharmaceutics CrossRef - Preparation and Applications of Organo-Silica Hybrid Mesoporous Silica Nanoparticles for the Co-Delivery of Drugs and Nucleic Acids
Iris Pontón et al, 2020, Nanomaterials CrossRef - The Potential of Nanotechnology in Medically Assisted Reproduction
Mariana H. Remião et al, 2018, Frontiers in Pharmacology CrossRef - Recent advances in drug delivery systems for targeting cancer stem cells
Hongxia Duan et al, 2021, Acta Pharmaceutica Sinica B CrossRef - Nanoparticles and Stem Cells
Suchandra Chowdhury et al, 2021, Stem Cells CrossRef - Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation
Leila Asadollahi et al, 2022, International Journal of Pharmaceutics CrossRef